-
1
-
-
0027475985
-
A Canadian multi-center placebo-controlled study of fixed doses of nsperidone and haloperidol in the treatment of chronic schizophrenic patients
-
Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G.W., Labelle, A., Beauclair, L. and Arnott, W. (1993) A Canadian multi-center placebo-controlled study of fixed doses of nsperidone and haloperidol in the treatment of chronic schizophrenic patients. J. Clin. Psychopharmacol. 13, 25-40.
-
(1993)
J. Clin. Psychopharmacol.
, vol.13
, pp. 25-40
-
-
Chouinard, G.1
Jones, B.2
Remington, G.3
Bloom, D.4
Addington, D.5
MacEwan, G.W.6
Labelle, A.7
Beauclair, L.8
Arnott, W.9
-
2
-
-
0022668286
-
A randomized controlled trial of prophylactic neuroleptic therapy
-
Crow, T.J., MacMillan, J.F., Johnson, A.L. and Johnstone, E.C. (1986) A randomized controlled trial of prophylactic neuroleptic therapy. Br. J. Psychiatr. 148, 120-127.
-
(1986)
Br. J. Psychiatr.
, vol.148
, pp. 120-127
-
-
Crow, T.J.1
MacMillan, J.F.2
Johnson, A.L.3
Johnstone, E.C.4
-
3
-
-
0041394300
-
Risperidone in the treatment of first-episode patients with schizophreniform disorder: A double-blind, multi-centre study
-
Florence, March 1995
-
Emsley, R.A., McCreadie, R., Livingston, M., de Smedt, G. and Lemmens, P. (1995) Risperidone in the treatment of first-episode patients with schizophreniform disorder: a double-blind, multi-centre study [Poster]. Presented at Campaign on Schizophrenia Conference "Critical Issues in Treatment", Florence, March 1995.
-
(1995)
Campaign on Schizophrenia Conference "Critical Issues in Treatment"
-
-
Emsley, R.A.1
McCreadie, R.2
Livingston, M.3
De Smedt, G.4
Lemmens, P.5
-
4
-
-
0026788261
-
Duration of psychosis and outcome in first-episode schizophrenia
-
Loebel, A.D., Lieberman, J.A., Alvir, J.M., Mayerhoff, D.I., Geisler, S.H. and Szymanski, S.R. (1992) Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatr. 149, 1183-1188.
-
(1992)
Am. J. Psychiatr.
, vol.149
, pp. 1183-1188
-
-
Loebel, A.D.1
Lieberman, J.A.2
Alvir, J.M.3
Mayerhoff, D.I.4
Geisler, S.H.5
Szymanski, S.R.6
-
5
-
-
0028342655
-
Risperidone in the treatment of schizophrenia
-
Marder, S.R. and Meibach, R.C. (1994) Risperidone in the treatment of schizophrenia. Am. J. Psychiatr. 151, 1825-1835.
-
(1994)
Am. J. Psychiatr.
, vol.151
, pp. 1825-1835
-
-
Marder, S.R.1
Meibach, R.C.2
-
6
-
-
0242627362
-
Dosing issues: Target symptoms and dose response
-
McEvoy, J. (1995) Dosing issues: target symptoms and dose response. Psychiatr. Ann. 25, 297-300.
-
(1995)
Psychiatr. Ann.
, vol.25
, pp. 297-300
-
-
McEvoy, J.1
-
7
-
-
0028865612
-
Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
-
Peuskens, J. and the Risperidone Study Group (1995) Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Br. J. Psychiatr. 166, 712-726.
-
(1995)
Br. J. Psychiatr.
, vol.166
, pp. 712-726
-
-
Peuskens, J.1
-
8
-
-
0016237473
-
Why do schizophrenic patients refuse to take their medication?
-
Van Putten, T. (1974) Why do schizophrenic patients refuse to take their medication? Arch. Gen. Psychiatr. 31, 67-72.
-
(1974)
Arch. Gen. Psychiatr.
, vol.31
, pp. 67-72
-
-
Van Putten, T.1
-
9
-
-
0026040246
-
Neuroleptics and the natural course of schizophrenia
-
Wyatt, R. (1991) Neuroleptics and the natural course of schizophrenia. Schizophr. Bull. 17, 325-351.
-
(1991)
Schizophr. Bull.
, vol.17
, pp. 325-351
-
-
Wyatt, R.1
|